The US Bankruptcy Court granted an order for the extension of the exclusivity periods for Pear Therapeutics, Inc. on December 13, 2023. As per the order, the debtor?s exclusivity period to file its plan and to solicit votes on its plan, have been extended by 90 days up to February 5, 2024 and April 1, 2024, respectively.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- USD | -.--% | -.--% | -.--% |
May. 23 | Pear Therapeutics, Inc. Went Out of Business | CI |
May. 08 | Combined Liquidation Plan and Disclosure Statement Approved for Pear Therapeutics, Inc. | CI |
1st Jan change | Capi. | |
---|---|---|
-.--% | 142 | |
+48.08% | 54.63B | |
-5.69% | 39.92B | |
+36.73% | 38.82B | |
+14.62% | 26.86B | |
-12.56% | 26.22B | |
-21.68% | 18.78B | |
+27.08% | 12.21B | |
+1.67% | 12.16B | |
+28.21% | 11.94B |
- Stock Market
- Equities
- PEAR Stock
- News Pear Therapeutics, Inc.
- Second Motion for Exclusivity Period Extension Approved For Pear Therapeutics, Inc.